Annual report [Section 13 and 15(d), not S-K Item 405]

BUSINESS (Details Narrative)

v3.26.1
BUSINESS (Details Narrative) - BioCorRx Pharmaceuticals, Inc [Member]
Jul. 28, 2016
Management fee 24.20%
Ownership retained percent 75.80%